Molecular mechanisms underlying oxytocin-induced cardiomyocyte protection from simulated ischemia-reperfusion

Molecular and Cellular Endocrinology

Volumn 412, Issue , 2015, Pages 170-181

  Gonzalez Reyes, Araceli ^a,b   Menaouar, Ahmed ^a   Yip, Denis ^a,b   Danalache, Bogdan ^a   Plante, Eric ^a   Noiseux, Nicolas ^c   Gutkowska, Jolanta ^a,c   Jankowski, Marek ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Cardiomyocyte; Ischemia reperfusion; Mitochondria; Oxytocin; Signal transduction

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP DEPENDENT PROTEIN KINASE; FORMAZAN; KT 5823; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; OXYTOCIN; OXYTOCIN RECEPTOR; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; WORTMANNIN; CARDIOTONIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; H9C2 CELL LINE; HEART MUSCLE CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; ISCHEMIA; MICROSCOPY; MOLECULAR MECHANICS; MYOBLAST; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; WESTERN BLOTTING; CARDIAC MUSCLE CELL; CELL CULTURE; CELL HYPOXIA; CELL LINE; DRUG EFFECTS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY; PRECLINICAL STUDY; PROTEIN PROCESSING;

CARDIOTONIC AGENTS; CELL HYPOXIA; CELL LINE; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DRUG EVALUATION, PRECLINICAL; MYOBLASTS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXYTOCIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RECEPTORS, OXYTOCIN;

EID: 84939573492     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.04.028     Document Type: Article

References (51)

1. Alizadeh A.M., Faghihi M., Sadeghipour H.R., Mohammadghasemi F., Imani A., Houshmand F., et al. Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel. Peptides 2010, 31:1341-1345.
2. Alizadeh A.M., Faghihi M., Khori V., Sohanaki H., Pourkhalili K., Mohammadghasemi F., et al. Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore. Peptides 2012, 36:71-77.
3. Baird N.A., Turnbull D.W., Johnson E.A. Induction of the heat shock pathway during hypoxia requires regulation of heat shock factor by hypoxia-inducible factor-1. J. Biol. Chem 2006, 281:38675-38681.
4. Cohen M.V., Yang X.M., Downey J.M. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res. Cardiol 2008, 103:464-471.
5. Conti F., Sertic S., Reversi A., Chini B. Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 "short cycle. Am. J. Physiol. Endocrinol. Metab 2009, 296:E532-E542.
6. Daiber A. Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim. Biophys. Acta 2010, 1797:897-906.
7. Danalache B.A., Paquin J., Donghao W., Grygorczyk R., Moore J.C., Mummery C.L., et al. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells 2007, 25:679-688.
8. Das B., Sarkar C. Is preconditioning by oxytocin administration mediated by iNOS and/or mitochondrial K(ATP) channel activation in the in vivo anesthetized rabbit heart?. Life Sci 2012, 90:763-769.
9. Duran W.N., Breslin J.W., Sanchez F.A. The NO cascade, eNOS location, and microvascular permeability. Cardiovasc. Res 2010, 87:254-261.
10. Favaretto A.L., Ballejo G.O., Albuquerque-Araujo W.I., Gutkowska J., Antunes-Rodrigues J., McCann S.M. Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action. Peptides 1997, 18:1377-1381.
11. Feron O., Balligand J.L. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc. Res 2006, 69:788-797.
12. Florian M., Jankowski M., Gutkowska J. Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology 2010, 151:482-491.
13. Garlid K.D., Costa A.D., Quinlan C.L., Pierre S.V., Dos Santos P. Cardioprotective signaling to mitochondria. J. Mol. Cell. Cardiol 2009, 46:858-866.
14. Gassanov N., Devost D., Danalache B., Noiseux N., Jankowski M., Zingg H.H., et al. Functional activity of the carboxyl-terminally extended oxytocin precursor peptide during cardiac differentiation of embryonic stem cells. Stem Cells 2008, 26:45-54.
15. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev 2001, 81:629-683.
16. Guevara I., Iwanejko J., Dembinska-Kiec A., Pankiewicz J., Wanat A., Anna P., et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 1998, 274:177-188.
17. Gutkowska J., Jankowski M. Oxytocin revisited: its role in cardiovascular regulation. J. Neuroendocrinol 2012, 24:599-608.
18. Harvey R.D., Calaghan S.C. Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology. J. Mol. Cell. Cardiol 2012, 52:366-375.
19. Haubner B.J., Neely G.G., Voelkl J.G., Damilano F., Kuba K., Imai Y., et al. PI3Kgamma protects from myocardial ischemia and reperfusion injury through a kinase-independent pathway. PLoS ONE 2010, 5:e9350.
20. Hausenloy D.J., Tsang A., Mocanu M.M., Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am. J. Physiol. Heart Circ. Physiol 2005, 288:H971-H976.
21. Hausenloy D.J., Ong S.B., Yellon D.M. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res. Cardiol 2009, 104:189-202.
22. Heusch G., Boengler K., Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919.
23. Heusch G., Boengler K., Schulz R. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res. Cardiol 2010, 105:151-154.
24. Hong L., Xi J., Zhang Y., Tian W., Xu J., Cui X., et al. Atrial natriuretic peptide prevents the mitochondrial permeability transition pore opening by inactivating glycogen synthase kinase 3beta via PKG and PI3K in cardiac H9c2 cells. Eur. J. Pharmacol 2012, 695:13-19.
25. Indrambarya T., Boyd J.H., Wang Y., McConechy M., Walley K.R. Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice. Crit. Care 2009, 13:R98.
26. Jankowski M., Bissonauth V., Gao L., Gangal M., Wang D., Danalache B., et al. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res. Cardiol 2010, 105:205-218.
27. Joy S., Siow R.C., Rowlands D.J., Becker M., Wyatt A.W., Aaronson P.I., et al. The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J. Biol. Chem 2006, 281:27335-27345.
28. Kim H.J., Joo H.J., Kim Y.H., Ahn S., Chang J., Hwang K.B., et al. Systemic analysis of heat shock response induced by heat shock and a proteasome inhibitor MG132. PLoS ONE 2011, 6:e20252.
29. Kim Y.S., Ahn Y., Kwon J.S., Cho Y.K., Jeong M.H., Cho J.G., et al. Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury. Cells Tissues Organs 2012, 195:428-442.
30. Kinsey C.G., Bussolati G., Bosco M., Kimura T., Pizzorno M.C., Chernin M.I., et al. Constitutive and ligand-induced nuclear localization of oxytocin receptor. J. Cell. Mol. Med 2007, 11:96-110.
31. Kobayashi H., Yasuda S., Bao N., Iwasa M., Kawamura I., Yamada Y., et al. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis. J. Cardiovasc. Pharmacol 2009, 54:510-519.
32. Koneru S., Penumathsa S.V., Thirunavukkarasu M., Samuel S.M., Zhan L., Han Z., et al. Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am. J. Physiol. Heart Circ. Physiol 2007, 292:H2060-H2072.
33. Li X., Chan T.O., Myers V., Chowdhury I., Zhang X.Q., Song J., et al. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Galphaq-mediated cell signaling. Circulation 2011, 124:572-581.
34. Link H., Dayanithi G., Fohr K.J., Gratzl M. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively. Endocrinology 1992, 130:2183-2191.
35. Manning M., Misicka A., Olma A., Bankowski K., Stoev S., Chini B., et al. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J. Neuroendocrinol 2012, 24:609-628.
36. Menaouar A., Florian M., Wang D., Danalache B., Jankowski M., Gutkowska J. Anti-hypertrophic effects of oxytocin in rat ventricular myocytes. Int. J. Cardiol 2014, 175(1):38-49.
37. Mocanu M.M., Bell R.M., Yellon D.M. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J. Mol. Cell. Cardiol 2002, 34:661-668.
38. Moghimian M., Faghihi M., Karimian S.M., Imani A., Houshmand F., Azizi Y. Role of central oxytocin in stress-induced cardioprotection in ischemic-reperfused heart model. J. Cardiol 2013, 61:79-86.
39. Mukaddam-Daher S., Yin Y.L., Roy J., Gutkowska J., Cardinal R. Negative inotropic and chronotropic effects of oxytocin. Hypertension 2001, 38:292-296.
40. Murphy E., Wong R., Steenbergen C. Signalosomes: delivering cardioprotective signals from GPCRs to mitochondria. Am. J. Physiol. Heart Circ. Physiol 2008, 295:H920-H922.
41. Noiseux N., Borie M., Desnoyers A., Menaouar A., Stevens L.M., Mansour S., et al. Preconditioning of stem cells by oxytocin to improve their therapeutic potential. Endocrinology 2012, 153:5361-5372.
42. Ondrejcakova M., Ravingerova T., Bakos J., Pancza D., Jezova D. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion. Can. J. Physiol. Pharmacol 2009, 87:137-142.
43. Ondrejcakova M., Barancik M., Bartekova M., Ravingerova T., Jezova D. Prolonged oxytocin treatment in rats affects intracellular signaling and induces myocardial protection against infarction. Gen. Physiol. Biophys 2012, 31:261-270.
44. Perrelli M.G., Pagliaro P., Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J. Cardiol 2011, 3:186-200.
45. Piper H.M., Abdallah Y., Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc. Res 2004, 61:365-371.
46. Postina R., Kojro E., Fahrenholz F. Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J. Biol. Chem 1996, 271:31593-31601.
47. Quinlan C.L., Costa A.D., Costa C.L., Pierre S.V., Dos Santos P., Garlid K.D. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am. J. Physiol. Heart Circ. Physiol 2008, 295:H953-H961.
48. Reversi A., Rimoldi V., Marrocco T., Cassoni P., Bussolati G., Parenti M., et al. The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J. Biol. Chem 2005, 280:16311-16318.
49. Rowlands D.J., Chapple S., Siow R.C., Mann G.E. Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signaling in endothelial cells: roles for F-actin and GPR30. Hypertension 2011, 57:833-840.
50. Sun J., Kohr M.J., Nguyen T., Aponte A.M., Connelly P.S., Esfahani S.G., et al. Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins. Antioxid. Redox Signal 2012, 16:45-56.
51. Wang D., Gutkowska J., Marcinkiewicz M., Rachelska G., Jankowski M. Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats. Cardiovasc. Res 2003, 57:186-194.